OCS
Oculis Holding AGNASDAQStock$12.97+0.01 (+0.08%)Mkt Cap 741.5MP/E —Div Yield —Beta 0.23Vol 51.4KAvg Vol 591.4K
52W$10.71
$32.65
ETFs That Hold OCS (Oculis Holding AG)
1M
+17.70%
3M
-56.26%
6M
-55.90%
YTD
-35.15%
1Y
-26.01%
3Y
-3.57%
5Y
+34.13%
ETFs That Hold OCS
Oculis Holding AG is held by 4 ETFs. The largest position by market value is in SBIO (ALPS Medical Breakthroughs ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | 0.38% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.72% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.00% |
| GLCR | GlacierShares Nasdaq Iceland ETF | 7.12% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold OCS?
Oculis Holding AG (OCS) is held by 4 ETFs (excluding leveraged and inverse funds). The largest position by market value is in SBIO (ALPS Medical Breakthroughs ETF).
What is the largest ETF that holds OCS?
By fund size, SBIO (ALPS Medical Breakthroughs ETF) with $232.7M in AUM holds 0.38% of its portfolio in OCS, representing $878K in market value.
What percentage of GLCR is OCS?
OCS makes up 7.12% of GLCR (GlacierShares Nasdaq Iceland ETF), making it one of the largest positions in that fund.
Is OCS in the S&P 500?
OCS is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.